Macquarie Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $48.7M | Buy |
|
|||||
|
2025
Q2 | $40.3M | Sell |
|
|||||
|
2025
Q1 | $50M | Sell |
|
|||||
|
2024
Q4 | $53.4M | Buy |
|
|||||
|
2024
Q3 | $79M | Sell |
|
|||||
|
2024
Q2 | $80.3M | Sell |
|
|||||
|
2024
Q1 | $74M | Sell |
|
|||||
|
2023
Q4 | $69.2M | Sell |
|
|||||
|
2023
Q3 | $83.7M | Buy |
|
|||||
|
2023
Q2 | $72.8M | Sell |
|
|||||
|
2023
Q1 | $141M | Sell |
|
|||||
|
2022
Q4 | $173M | Sell |
|
|||||
|
2022
Q3 | $178M | Sell |
|
|||||
|
2022
Q2 | $165M | Sell |
|
|||||
|
2022
Q1 | $199K | Buy |
|
|||||
|
2021
Q4 | $173M | Buy |
|
|||||
|
2021
Q3 | $132M | Buy |
|
|||||
|
2021
Q2 | $59.2M | Buy |
|
|||||
|
2021
Q1 | $48.8M | Buy |
|
|||||
|
2020
Q4 | $49.4M | Buy |
|
|||||
|
2020
Q3 | $55M | Buy |
|
|||||
|
2020
Q2 | $58.5M | Buy |
|
|||||
|
2020
Q1 | $40.8M | Sell |
|
|||||
|
2019
Q4 | $39.5M | Sell |
|
|||||
|
2019
Q3 | $29.2M | Buy |
|
|||||
|
2019
Q2 | $24.2M | Buy |
|
|||||
|
2019
Q1 | $27.3M | Sell |
|
|||||
|
2018
Q4 | $31.5M | Buy |
|
|||||
|
2018
Q3 | $28.4M | Buy |
|
|||||
|
2018
Q2 | $23.3M | Buy |
|
|||||
|
2018
Q1 | $21.3M | Buy |
|
|||||
|
2017
Q4 | $20.1M | Buy |
|
|||||
|
2017
Q3 | $12M | Sell |
|
|||||
|
2017
Q2 | $15.5M | Buy |
|
|||||
|
2017
Q1 | $12.1M | Sell |
|
|||||
|
2016
Q4 | $14.3M | Sell |
|
|||||
|
2016
Q3 | $15.7M | Sell |
|
|||||
|
2016
Q2 | $24.6M | Buy |
|
|||||
|
2016
Q1 | $11.8M | Sell |
|
|||||
|
2015
Q4 | $21.1M | Sell |
|
|||||
|
2015
Q3 | $18.7M | Buy |
|
|||||
|
2015
Q2 | $18.1M | Hold |
|
|||||
|
2015
Q1 | $16M | Buy |
|
|||||
|
2014
Q4 | $14.5M | Buy |
|
|||||
|
2014
Q3 | $11.2M | Buy |
|
|||||
|
2014
Q2 | $8.25M | Sell |
|
|||||
|
2014
Q1 | $9.22M | Buy |
|
|||||
|
2013
Q4 | $7.16M | Buy |
|
|||||
|
2013
Q3 | $7.79M | Hold |
|
|||||
|
2013
Q2 | $5.6M | Buy |
|